HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Early results of transversalis-plasty. A prospective randomized comparison of non-resorbable and resorbable sutures].

Abstract
In a prospective randomized trial we analyzed the perioperative management, complications, and the recurrence rate of inguinal hernia repair using either resorbable (polydioxanone, PDS) or non-absorbable (polyamide, Ethilon) suture material. From January 1988 to June 1989, 484 consecutive transversalis fascia repairs were performed in 425 adult patients with inguinal or femoral hernia. Local anaesthesia was used in 273 cases. At least one year postoperatively, 390 patients with 445 repairs had a clinical follow-up. The recurrence rate after 360 primary herniae was 3.3% (Ethilon 2.3%, PDS 4.3%) while 5.9% rerecurrences were found following operation for recurrent hernia (Ethilon 2.5%, PDS 8.9%). The differences in the recurrence rates following the use of polyamide or polydioxanone were not statistically significant. Complications occurred in 5.2%. The postoperative hospital stay averaged 3.8 days and work was resumed after a mean of 3.9 weeks.
AuthorsJ C Küttel, R Peterli, C Schüpfer, R Horn, C Muller, U Grötzinger
JournalHelvetica chirurgica acta (Helv Chir Acta) Vol. 57 Issue 6 Pg. 931-4 (May 1991) ISSN: 0018-0181 [Print] Switzerland
Vernacular TitleFrühergebnisse nach Transversalisplastik. Ein prospektiv randomisierter Vergleich von nichtresorbierbarem und resorbierbarem Nahtmaterial.
PMID1909693 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Nylons
  • Polyesters
  • Polydioxanone
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Fasciotomy
  • Hernia, Femoral (surgery)
  • Hernia, Inguinal (surgery)
  • Humans
  • Middle Aged
  • Nylons
  • Polydioxanone
  • Polyesters
  • Prospective Studies
  • Sutures

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: